Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7606123 | 0.88 | MAOB (0.50) | RAB9ASMN1; SMN2KDM4EHPGDTLR9 | |
| SCHEMBL12772142 | 0.88 | MAPT (0.46) | RAB9ASMN1; SMN2LTA4HKDM4EHPGD | |
| SCHEMBL1539317 | 0.87 | SMN1; SMN2 (0.47) | RAB9ASMN1; SMN2LTA4HKDM4EHPGD | |
| SCHEMBL12772163 | 0.86 | RAB9A (0.56) | RAB9ASMN1; SMN2KDM4EHPGDTLR9 | |
| SCHEMBL2860906 | 0.82 | RAB9A (0.50) | RAB9ASMN1; SMN2KDM4EHPGDTLR9 | |
| SCHEMBL12772058 | 0.80 | LTA4H (0.64) | LTA4H | |
| SCHEMBL18623184 | 0.79 | MAOB (0.60) | RAB9ASMN1; SMN2ABCB1 | |
| SCHEMBL5430708 | 0.79 | MAPT (0.43) | RAB9ASMN1; SMN2KDM4EHPGDMAPT | |
| SCHEMBL5276838 | 0.78 | RAB9A (0.51) | RAB9ASMN1; SMN2KDM4EHPGDTLR9 | |
| SCHEMBL6809786 | 0.78 | RAB9A (0.46) | RAB9ASMN1; SMN2KDM4EHPGDTLR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8115017-B2 | C-phenyl 1-thioglucitol compound | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20100004465-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004465-A1 | C-PHENYL 1-THIOGLUCITOL COMPOUND | SLC5A1, SLC5A2, SLC2A1 | RAB9A 2179/4885SMN1; SMN2 4505/4885LTA4H 2679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.